# Autologous Hematopoietic Stem Cell Transplantation for Crohn's Disease Treatment

> **NCT01932658** · EARLY_PHASE1 · WITHDRAWN · sponsor: **University of California, Los Angeles**

## Conditions studied

- Crohn's Disease

## Interventions

- **BIOLOGICAL:** Hematopoietic stem cell transplantation

## Key facts

- **NCT ID:** NCT01932658
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-02
- **Primary completion:** 2016-03
- **Final completion:** 2017-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** patients insurance would not cover the cost of the study procedures
- **Last updated:** 2016-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01932658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01932658, "Autologous Hematopoietic Stem Cell Transplantation for Crohn's Disease Treatment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01932658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*